193 related articles for article (PubMed ID: 28695556)
21. Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study.
Afifi A; El Setouhy M; El Sharkawy M; Ali M; Ahmed H; El-Menshawy O; Masoud W
East Mediterr Health J; 2004; 10(4-5):620-6. PubMed ID: 16335654
[TBL] [Abstract][Full Text] [Related]
22. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
[TBL] [Abstract][Full Text] [Related]
23. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk.
Lorenzo V; Boronat M; Saavedra P; Rufino M; Maceira B; Novoa FJ; Torres A
Nephrol Dial Transplant; 2010 Jul; 25(7):2283-8. PubMed ID: 20064954
[TBL] [Abstract][Full Text] [Related]
24. Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention.
Sardi GL; Maluenda G; Torguson R; Xue Z; Suddath WO; Kent KM; Lindsay J; Satler LF; Pichard AD; Waksman R
J Interv Cardiol; 2012 Apr; 25(2):147-55. PubMed ID: 22010995
[TBL] [Abstract][Full Text] [Related]
25. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
[TBL] [Abstract][Full Text] [Related]
26. [Increase in prevalence of diabetes mellitus as a cause of dialytic end-stage renal disease: analysis of 20 years in the west region of Paraná].
Peres LA; Matsuo T; Delfino VD; Peres CP; Almeida Netto JH; Ann HK; Camargo MT; Rohde NR; Uscocovich VF
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):111-5. PubMed ID: 17435864
[TBL] [Abstract][Full Text] [Related]
27. Diabetic CKD/ESRD 2010: a progress report?
Williams ME
Semin Dial; 2010; 23(2):129-33. PubMed ID: 20210917
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
[TBL] [Abstract][Full Text] [Related]
29. Diabetes mellitus: the leading cause of haemodialysis in Jordan.
Abdallah S; Ahmad AT; Batieha A; Ajlouni K
East Mediterr Health J; 2007; 13(4):803-9. PubMed ID: 17955762
[TBL] [Abstract][Full Text] [Related]
30. Minor impairment of oral iron absorption in non-diabetic new dialysis patients.
Tovbin D; Schnaider A; Vorobiov M; Rogachev B; Basok A; Shull P; Novack V; Friger M; Avramov D; Zlotnik M
J Nephrol; 2005; 18(2):174-80. PubMed ID: 15931645
[TBL] [Abstract][Full Text] [Related]
31. Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes.
Lopes AA; Port FK
Am J Kidney Dis; 1995 May; 25(5):714-21. PubMed ID: 7747725
[TBL] [Abstract][Full Text] [Related]
32. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
[TBL] [Abstract][Full Text] [Related]
33. Diabetic nephropathy as a cause of end-stage renal disease in Tabuk area, Saudi Arabia: a four-year study.
El Minshawy O; Ghabrah T; El Bassuoni E
Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):1105-9. PubMed ID: 25193923
[TBL] [Abstract][Full Text] [Related]
34. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
Villar E; Chang SH; McDonald SP
Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
[TBL] [Abstract][Full Text] [Related]
35. Elderly diabetic patients on peritoneal dialysis.
Passadakis P; Oreopoulos DG
Adv Perit Dial; 2009; 25():140-6. PubMed ID: 19886336
[TBL] [Abstract][Full Text] [Related]
36. Options in uraemia therapy for diabetics with end-stage renal disease.
Polenaković MH
Prilozi; 2004; 25(1-2):27-51. PubMed ID: 15735534
[TBL] [Abstract][Full Text] [Related]
37. Trends of incident dialysis patients in Tunisia between 1992 and 2001.
Counil E; Cherni N; Kharrat M; Achour A; Trimech H
Am J Kidney Dis; 2008 Mar; 51(3):463-70. PubMed ID: 18295062
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and progression of peripheral arterial calcifications in patients with ESRD.
Kronenberg F; Mündle M; Längle M; Neyer U
Am J Kidney Dis; 2003 Jan; 41(1):140-8. PubMed ID: 12500231
[TBL] [Abstract][Full Text] [Related]
39. Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas French territories. A second national survey six years apart. (UREMIDIAB 2 study).
Halimi S; Zmirou D; Benhamou PY; Balducci F; Zaoui P; Maghlaoua M; Cordonnier D
Diabetes Metab; 1999 Dec; 25(6):507-12. PubMed ID: 10633876
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories.
Cordonnier DJ; Zmirou D; Benhamou PY; Halimi S; Ledoux F; Guiserix J
Diabetologia; 1993 Oct; 36(10):1109-12. PubMed ID: 8243863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
